Search results for: 'Active Ingredients for cosmetics'

The trend opportunity profile series covers specific opportunities emerging from future trend evolutions designed to help clients discover and prioritize the most consequential medium-to-long-term trends that are actively transforming their businesses’ growth environment. These trend opportunity profiles cover 11 key industries: including aerospace...

With customers adapting to the post-pandemic normal and preferring to stay at home, brands across the globe are seeking solutions to meet the increased demand for online services. The relatively sudden and significant increase in eCommerce has made it challenging for companies to maintain a workforce for customer assistance. Brands are relying on t...

Buy now, pay later (BNPL), also referred to as point of sale (PoS) installment loans, is a short-term financing option that enables consumers to spread out payments for purchases over a period of time. The increase in eCommerce activity during the COVID-19 pandemic brought along with it a strong interest in alternative spending options. BNPL, a sub...

06 Feb 2018  |  Global  |  Market Research

Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows

Infographics

×

Key Issues Addressed

The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe. Increasing clinical trial activities in the emerging Asia-Pacific markets and r...

23 May 2017  |  North America  |  Market Research

Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021

US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation

Infographics

×

The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...

29 May 2017  |  Europe  |  Market Research

Growth Opportunities in the Spanish Facility Management Market

Strong Opportunities for Service Integration and Hard Services in Europe’s Fastest Growing FM Market

Infographics

×

Spain is one of the smallest Facility Management (FM) markets in Europe on a per capita revenue basis. As FM awareness increases and outsourcing becomes more widely accepted, its growth will be the highest in all of Europe in all three delivery models (single-service, bundled service, and Integrated Facility Management or IFM). While soft-service F...

06 Jun 2017  |  Global  |  Market Research

Internet of Medical Things, Forecast to 2021

Growth Opportunities, Challenges, and Future Perspectives in Healthcare

Infographics

×

Healthcare is one of the industries facing disruption by technological advances in the Internet of Things (IoT) space, and yet it is only partially aware of the advances, potential, and benefits. Almost 60% of healthcare organizations have already adopted healthcare IoT or Internet of Medical Things (IoMT), and realized cost savings, improved their...

05 Jul 2017  |  North America  |  Megatrends

Smart Cities Funding Models

Bridging the Funding Gap of the Next Trillion-dollar Market

Infographics

×

Smart Cities are cities built on ‘Smart’ and ‘Intelligent’ solutions and technology which will lead to the adoption of at least 5 of the 8 following smart parameters: smart energy, smart building, smart mobility, smart healthcare, smart infrastructure, smart technology, smart governance and smart education, and smart citizen. The Smart Cities marke...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...